REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Uromedica S A (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Uromedica S A Profile Updated: February 20, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Promover y realizar investigaciones medicas y farmaceuticas, promover la educacion medica continuada, especialmente en el area de urologia, fabricar, envasar, producir, preparar, aprovechar, investiga.

Headquarters
Cra 15 N 84-24 Ofc 316
Bogota D.C.; Bogota D.C; Postal Code: 0806

Contact Details: Purchase the Uromedica S A report to view the information.

Basic Information
Total Employees:
Purchase the Uromedica S A report to view the information.
Outstanding Shares:
Purchase the Uromedica S A report to view the information.
Incorporation Date:
September 12, 2000
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Uromedica S A report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
288.3%▲
Total operating revenue
288.3%▲
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
51.57%▲
Total equity
-8.85%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-4.57%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo